Mix Japan Survey: 90% Of 2014 Drugs That Fall Under New Drug Premium Were Also Applicable In 2010-2013
This article was originally published in PharmAsia News
Executive Summary
Based on a questionnaire to Japanese pharmaceutical companies carried out by Mix, 90% of the drugs that applied for the premium to promote the development of new drugs and eliminate off-label use in the 2014 drug price reforms were also applicable in the three consecutive years since 2010.